Nuclear morphometry and the MIB-1 index in rhabdomyosarcoma

Modern Pathology

Volumn 9, Issue 3, 1996, Pages 253-260

  Noguchi, Shin Ichi ^a   Tamiya, Sadafumi ^a   Nagoshi, Makoto ^a   Suita, Sachiyo ^a   Fukuda, Toshiro ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Factors; MIB 1; Nuclear morphometry; Prognostic; Rhabdomyosarcoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELL NUCLEUS; CHILD; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; IMMUNOLOGY; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; STAINING;

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; TUMOR ANTIGEN; TUMOR PROTEIN;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KI-67 ANTIGEN; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROGNOSIS; RHABDOMYOSARCOMA; STAINING AND LABELING;

EID: 0030097153     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Horn RC, Enterline HT: Rhabdomyosarcoma: A clinicopathological study and classification of 39 cases. Cancer 11:181, 1958.
2. Enzinger FM, Lattes R, Torlani H: Histopathological typing of soft tissue tumors. In International Histopathological Classification of Tumors, No 3. Geneva, World Health Organization, 1969.
3. Newton WA, Soule EH, Hamoudi AB, et al.: Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: Clinicopathologic correlation. J Clin Oncol 6:67, 1958.
4. Caillaud JM, Gerard-Marchant R, Marsden HB, et al.: Histopathological classification of childhood rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Pathology Panel. Med Pediatr Oncol 17:391, 1989.
5. Tsokos M, Webber BL, Parham DM, et al.: Rhabdomyosarcoma: A new classification scheme related to prognosis. Arch Pathol Lab Med 116:847, 1992.
6. Wijnaendts LCD, van der Linden JC, van Unnik AJM, et al.: Histopathological classification of childhood rhabdomyosarcomas: Relationship with clinical parameters and prognosis. Hum Pathol 25:900, 1994.
7. Cavazzana AO, Schmidt D, Ninfo V, et al.: Spindle cell rhabdomyosarcoma: A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol 16:229, 1992.
8. Weiss SW (ed): Histopathological typing of soft tissue tumors, Ed 2. In International Histopathological Classification of Tumors. Geneva, World Health Organization, 1994.
9. Leonard MP, Partin AW, Epstein JI, et al.: Nuclear morphometry as a prognostic indicator for genitourinary rhabdomyosarcoma: A preliminary investigation. J Urol 144:1222, 1990.
10. Kuratsu S, Aozasa K, Myoui A, et al.: Prognostic significance of argyrophilic nucleolar organizer staining in soft-tissue sarcomas. Int J Cancer 48:211, 1991.
11. Oda Y, Hashimoto H, Takeshita S, et al.: The prognostic values of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer 72:478, 1993.
12. Ueda T, Aozasa K, Tsujimoto M, et al:. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 63:1607, 1989.
13. Zehr RJ, Bauer TW, Marks K, et al.: Ki-67 and grading of malignant fibrous histiocytomas. Cancer 66:1984, 1990.
14. Michie BA, Black C, Reid RP, et al.: Image analysis derived ploidy and proliferation indices in soft tissue sarcomas: Comparison with clinical outcome. J Clin Pathol 47:443, 1994.
15. Oshiro Y, Fukuda T, Tsuneyoshi M: Atypical flbroxanthoma versus benign and malignant fibrous histiocytoma: A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53. Cancer 75:1128, 1995.
16. Gerdes J, Schwab U, Lemke H, et al.: Production of a monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13, 1983.
17. Key G, Becker MHG, Duchrow M, et al.: New Ki-67 equivalent murine monoclonal antibodies (MIB1-3) prepared against recombinant parts of the Ki-67 antigen. Anal Cell Pathol 4:181, 1992.
18. Amada S, Nakano H, Tsuneyoshi M: Leiomyosarcoma versus bizarre leiomyomas of the uterus: A comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 14:134, 1995.
19. Baak JPA, Kurver PHJ, De Snoo-Niewlaat AJE, et al.: Prognostic indicators in breast cancer: Morphometric methods. Histopathology 6:327, 1982.
20. Epstein JI, Berry SJ, Eggleston JC: Nuclear roundness factor: A predictor of progression in untreated stage A2 prostate cancer. Cancer 54:1666, 1984.
21. Tosi P, Luzi P, Baak PJA, et al.: Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma. Cancer 58:2512, 1986.
22. Ooms ECM, Essed E, Veldhuizen RW, et al: The prognostic significance of morphometry in T1 bladder tumors. Histopathology 5:311, 1981.
23. Blomjous CEM, Schipper NW, Vos W, et al.: Comparison of quantitative and classic prognosticators in urinary bladder carcinoma: A multivariate analysis of DNA flow cytometric, nuclear morphometric, and clinicopathological features. Virchows Archiv A Pathol Anat Histopathol 415:421, 1989.
24. Nishihara K, Tsuneyoshi M: Papillary cystic tumors of the pancreas: An analysis by nuclear morphometry. Virchows Archiv A Pathol Anat Histopathol 422:211, 1993.
25. Leuschner I, Newton WA, Schmidt D, et al.: Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region: A report of the Intergroup Rhabdomyosarcoma Study. Am J Surg Pathol 17:221, 1993.
26. Pich A, Ponti R, Valente G, et al.: MIB-1, Ki-67, and PCNA scores and DNA flow cytometry in intermediate-grade malignant lymphomas. J Clin Pathol 47:18, 1994.